With a presence spanning over five decades, we have enriched the industry through pioneering work aimed at making a significant impact on people’s lives.
Revenue from operations
y-o-y
Earnings before interest, tax, depreciation and amortization (EBITDA)
y-o-y
Profit after tax (PAT)
y-o-y
Net cash
At Alkem, our credo, “Inspiring Healthier Lives” is at the core of our research-driven innovation culture, enabling us to impact millions of lives worldwide positively. Reflecting on FY 2023-24, we made considerable progress in strengthening our operations, expanding our portfolio and pipeline, integrating new capabilities, and fostering the development of our people while attracting fresh talent across the organization.
Throughout our five-decade-long journey, Alkem has consistently evolved, expanding into new categories, businesses, and markets worldwide. This transformation has created significant opportunities, enabling us to scale growth and become a leading player in the Indian pharmaceutical industry.
In my first letter to you as the Chief Executive Officer, I take great pride in reporting on the progress Alkem has made during FY 2023-24. Alongside delivering strong financial results, we achieved several operational milestones, including successful new product launches, market expansion, advancements in research and development, and improved manufacturing efficiencies, all of which have contributed to our overall growth trajectory.
We acknowledge our duty to ensure a safe and sustainable future.
Our initiatives are designed to provide meaningful support to society and empower vulnerable populations in the most effective ways.
Our approach to value creation focuses on driving innovation and strengthening market positioning.
We aim to deliver innovative solutions, enhance healthcare access, and solidify our leadership in the pharmaceutical industry.
Our remarkable fifty-year journey at Alkem stands as a testament to the dedication and hard work of our people.
Menu
